Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification.
Feola S, Haapala M, Peltonen K, Capasso C, Martins B, Antignani G, Federico A, Pietiäinen V, Chiaro J, Feodoroff M, Russo S, Rannikko A, Fusciello M, Koskela S, Partanen J, Hamdan F, Tähkä SM, Ylösmäki E, Greco D, Grönholm M, Kekarainen T, Eshaghi M, Gurvich OL, Ylä-Herttuala S, M Branca RM, Lehtiö J, Sikanen TM, Cerullo V. Feola S, et al. Among authors: antignani g. ACS Nano. 2021 Oct 26;15(10):15992-16010. doi: 10.1021/acsnano.1c04371. Epub 2021 Oct 4. ACS Nano. 2021. PMID: 34605646 Free PMC article.
Patient-Derived Organoids for Precision Cancer Immunotherapy.
Grönholm M, Feodoroff M, Antignani G, Martins B, Hamdan F, Cerullo V. Grönholm M, et al. Among authors: antignani g. Cancer Res. 2021 Jun 15;81(12):3149-3155. doi: 10.1158/0008-5472.CAN-20-4026. Epub 2021 Mar 9. Cancer Res. 2021. PMID: 33687948 Free PMC article. Review.
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses.
Hamdan F, Martins B, Feodoroff M, Giannoula Y, Feola S, Fusciello M, Chiaro J, Antignani G, Grönholm M, Ylösmäki E, Cerullo V. Hamdan F, et al. Among authors: antignani g. Mol Ther Methods Clin Dev. 2021 Feb 4;20:625-634. doi: 10.1016/j.omtm.2021.01.014. eCollection 2021 Mar 12. Mol Ther Methods Clin Dev. 2021. PMID: 33718513 Free PMC article.
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids.
Hamdan F, Ylösmäki E, Chiaro J, Giannoula Y, Long M, Fusciello M, Feola S, Martins B, Feodoroff M, Antignani G, Russo S, Kari O, Lee M, Järvinen P, Nisen H, Kreutzman A, Leusen J, Mustjoki S, McWilliams TG, Grönholm M, Cerullo V. Hamdan F, et al. Among authors: antignani g. J Immunother Cancer. 2021 Aug;9(8):e003000. doi: 10.1136/jitc-2021-003000. J Immunother Cancer. 2021. PMID: 34362830 Free PMC article.
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine.
Feola S, Russo S, Martins B, Lopes A, Vandermeulen G, Fluhler V, De Giorgi C, Fusciello M, Pesonen S, Ylösmäki E, Antignani G, Chiaro J, Hamdan F, Feodoroff M, Grönholm M, Cerullo V. Feola S, et al. Among authors: antignani g. Front Immunol. 2022 Apr 14;13:826164. doi: 10.3389/fimmu.2022.826164. eCollection 2022. Front Immunol. 2022. PMID: 35493448 Free PMC article.
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.
Feodoroff M, Hamdan F, Antignani G, Feola S, Fusciello M, Russo S, Chiaro J, Välimäki K, Pellinen T, Branca RM, Lehtiö J, D Alessio F, Bottega P, Stigzelius V, Sandberg J, Clancy J, Partanen J, Malmstedt M, Rannikko A, Pietiäinen V, Grönholm M, Cerullo V. Feodoroff M, et al. Among authors: antignani g. Oncoimmunology. 2024 Sep 25;13(1):2407532. doi: 10.1080/2162402X.2024.2407532. eCollection 2024. Oncoimmunology. 2024. PMID: 39351443 Free PMC article.
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.
Russo S, Feola S, Feodoroff M, Chiaro J, Antignani G, Fusciello M, D'Alessio F, Hamdan F, Pellinen T, Mölsä R, Tripodi L, Pastore L, Grönholm M, Cerullo V. Russo S, et al. Among authors: antignani g. Mol Ther Oncol. 2024 Jan 26;32(1):200766. doi: 10.1016/j.omton.2024.200766. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596301 Free PMC article.
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.
Feola S, Hamdan F, Russo S, Chiaro J, Fusciello M, Feodoroff M, Antignani G, D'Alessio F, Mölsä R, Stigzelius V, Bottega P, Pesonen S, Leusen J, Grönholm M, Cerullo V. Feola S, et al. Among authors: antignani g. J Immunother Cancer. 2024 Mar 8;12(3):e008342. doi: 10.1136/jitc-2023-008342. J Immunother Cancer. 2024. PMID: 38458776 Free PMC article.
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.
Chiaro J, Antignani G, Feola S, Feodoroff M, Martins B, Cojoc H, Russo S, Fusciello M, Hamdan F, Ferrari V, Ciampi D, Ilonen I, Räsänen J, Mäyränpää M, Partanen J, Koskela S, Honkanen J, Halonen J, Kuryk L, Rescigno M, Grönholm M, Branca RM, Lehtiö J, Cerullo V. Chiaro J, et al. Among authors: antignani g. Nat Commun. 2023 Nov 3;14(1):7056. doi: 10.1038/s41467-023-42668-7. Nat Commun. 2023. PMID: 37923723 Free PMC article.
11 results